India Streptomycin Market to grow at a steady rate During the Forecast Period
Growing number of infectious
diseases is expected to drive the growth of India streptomycin market during
the forecast period.
According
to TechSci Research report, “India Streptomycin Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By
Strength (100 mg, 200 mg, 300 mg, 400 mg, Others), By Distribution Channel
(Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Restless Legs
Syndrome (RLS), Seizures, Others), By End User (Adult v/s Paediatric), By
Company, By Region, Forecast & Opportunities, FY2026”, the India streptomycin market is expected to grow at a
steady rate during the forecast period. World Health Organization has included streptomycin
in the list of essential medicines that are safe and most effective medicines
required in the healthcare system. Streptomycin is used to treat number of
diseases such as tuberculosis, meningitis, throat Infection and so on. This is
expected to fuel the market growth through FY2026. Furthermore, rising use of
antibiotics in cell culture is further projected to bode well for the market
growth in the next 5 years. However, patent expiration and availability of
substitute products are some of the impediments that can restrict the market
growth over the next few years. Moreover, increasing
resistance to antibiotics is another major concern which might further reduce
the application of the drug thereby hindering the market growth during the
forecast period. For instance, according to Centers for Disease Control and
Prevention, it is estimated that around 2 million illnesses and 23,000 deaths occurs
due to antibiotic resistance every year.
Browse
XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC
on "
India Streptomycin
Market"
https://www.techsciresearch.com/report/india-streptomycin-market/7200.html
The India streptomycin market is segmented based on source, form, route
of administration, type of manufacturing process, distribution channel,
application, end user, company, and region. Based on end user, the market can
be fragmented into adult v/s pediatric. The adult segment is forecasted to dominate
the market during the forecast period. This dominance can be accredited to the
wide use of streptomycin in adults to treat number of infectious diseases.
Based on source, the market can be categorized into in-house v/s contract
manufacturing organizations. The in-house segment dominated the market until FY2020
as most of the leading companies focus on in house production owing to high
standardization and flexibility. Contract manufacturing organizations segment
is expected to witness high growth in the market as it saves cost and maximize
profits.
Macleods Pharmaceuticals Ltd.,
Abbott Healthcare Pvt Ltd. (AHPL), Hindustan Antibiotics Ltd. (HAL), Nestor
Pharmaceuticals Ltd., Nitin Lifesciences Ltd., Wockhardt Limited, Neon
Laboratories Ltd., Shalina Laboratories
Pvt. Ltd., Wellona Pharma Pvt. Ltd., Cipla Ltd. and others are
some of the leading players operating in India streptomycin market. Companies
operating in the market are using strategies such as product launches, mergers
and acquisitions and research collaborations to boost their share and increase
their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7200
Customers can also
request for 10% free customization on this report.
“India streptomycin market is expected to
witness growth during the forecast period owing to rising use of antibiotics in
cell culture. In addition to this, increasing awareness by various government
and non-government organizations to control the bacterial infectious disease
among people is further expected to create lucrative opportunities for the
market growth of India streptomycin market in the forthcoming years. Growing
number of antibiotic manufacturers coupled with presence of some of leading
generics manufacturers in the country are some other major factors that are
projected to bolster the market growth in the next 5 years.” said
Mr. Karan Chechi, Research Director with TechSci Research, a research based India
management consulting firm.
“India Streptomycin Market By Source (In-house v/s
Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By
Strength (100 mg, 200 mg, 300 mg, 400 mg, Others), By Distribution Channel
(Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Restless Legs
Syndrome (RLS), Seizures, Others), By End User (Adult v/s Paediatric), By
Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India streptomycin
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India streptomycin market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]